| Literature DB >> 23049905 |
Diego Garzón-Ospina1, Carolina López, Johanna Forero-Rodríguez, Manuel A Patarroyo.
Abstract
A completely effective vaccine for malaria (one of the major infectious diseases worldwide) is not yet available; different membrane proteins involved in parasite-host interactions have been proposed as candidates for designing it. It has been found that proteins encoded by the merozoite surface protein (msp)-7 multigene family are antibody targets in natural infection; the nucleotide diversity of three Pvmsp-7 genes was thus analyzed in a Colombian parasite population. By contrast with P. falciparum msp-7 loci and ancestral P. vivax msp-7 genes, specie-specific duplicates of the latter specie display high genetic variability, generated by single nucleotide polymorphisms, repeat regions, and recombination. At least three major allele types are present in Pvmsp-7C, Pvmsp-7H and Pvmsp-7I and positive selection seems to be operating on the central region of these msp-7 genes. Although this region has high genetic polymorphism, the C-terminus (Pfam domain ID: PF12948) is conserved and could be an important candidate when designing a subunit-based antimalarial vaccine.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23049905 PMCID: PMC3458108 DOI: 10.1371/journal.pone.0045962
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Estimates of DNA diversity and neutrality test for Pvmsp-7 genes from a Colombian population.
| n | Gene | Sites | Ss | S | Ps | H | Hd (se) | θw (se) | π (se) | Tajima | Fu & Li | Fu | Zns | ZZ | RM | |
| D | D | F | Fs | |||||||||||||
| 37 |
| 1,098 | 148 | 1 | 147 | 23 | 0.93 (0.03) | 0.0323 (0.001) | 0.0548 (0.003) | 2.094** | 1.810 | 2.287 | 7.64 | 0.339 | 0.173 | 22 |
| 37 |
| 1,131 | 142 | 19 | 123 | 28 | 0.96 (0.02) | 0.0301 (0.002) | 0.0357 (0.003) | 0.388 | 0.952 | 0.987 | -0.57 | 0.126 | 0.343 | 27 |
| 42 |
| 1,058 | 127 | 6 | 121 | 28 | 0.97 (0.01) | 0.0280 (0.002) | 0.0430 (0.003) | 1.420 | 1.584** | 1.818 | 2.12 | 0.232 | 0.334 | 13 |
Ss: Number of segregating sites, S: number of singleton sites, Ps: number of parsimony-informative sites, H: number of haplotypes, Hd: haplotype diversity, θW: Watterson estimator, π: nucleotide diversity. (se): Standard deviation. Sites excluded from the analysis: Pvmsp-7C: nucleotides 1 to 17 (amino acids 1 to 6), 544 to 546 (amino acid 182), 616 to 618 (amino acid 206), 625 to 627 (amino acid 209), 631 to 648 (amino acids 211 to 216), 655 to 666 (amino acids 219 to 222), 676 to 684 (amino acids 226 to 228), 706 to 708 (amino acid 236), 1,105 to 1,107 (amino acid 369) and nucleotides 1,168 to 1,191 (amino acids 390 to 397); Pvmsp-7H: nucleotides 436 to 450 (amino acids 146 to 150), 448 to 486 (amino acid 162), 568 to 627 (amino acids 190 to 200) and nucleotides 772 to 774 (amino acid 258); Pvmsp-7I: nucleotides 1 to 18 (amino acids 1 to 6), 421 to 522 (amino acids 141 to 174) and nucleotides 526 to 537 (amino acids 176 to 179).
: p<0.02, **: p<0.05.
Figure 1Alignment of deduced PvMSP-7C amino acid sequences, including the Sal-I sequence in which the three main allele types can be observed.
Dots indicate conserved residues and dashes represent gaps introduced for alignment.
Figure 2Alignment of deduced PvMSP-7H amino acid sequences, including the Sal-I sequence.
The alignment shows major allele types found in Colombian populations. Dots indicate conserved residues and dashes represent gaps introduced for alignment.
Figure 3Alignment of deduced PvMSP-7I amino acid sequences, including the Sal-I sequence in which the protein sequences differentiating major allele types can be observed.
Dots indicate conserved residues and dashes represent gaps introduced for alignment.
Average number of synonymous substitutions per synonymous site (dS) and non-synonymous substitutions per non-synonymous site (dN) covering all sequence pairs at the 5′-end, central region, 3′-end and complete gene.
| 5′-end | Central region | 3′-end | Full length gene | |||||
| dS (se) | dN (se) | dS (se) | dN (se) | dS (se) | dN (se) | dS (se) | dN (se) | |
|
| 0.070 (0.016)** | 0.011 (0.004) | 0.122 (0.023) | 0.287 (0.031)• | 0.004 (0.003) | 0.000 (0.000) | 0.053 (0.008) | 0.059 (0.007) |
|
| 0.059 (0.010)• | 0.010 (0.003) | 0.052 (0.016) | 0.162 (0.019)• | 0.010 (0.005) | 0.005 (0.002) | 0.038 (0.006) | 0.037 (0.005) |
|
| 0.041 (0.014) | 0.020 (0.007) | 0.060 (0.019) | 0.186 (0.021)• | 0.017 (0.007) | 0.007 (0.003) | 0.036 (0.007) | 0.048 (0.006) |
se: standard error. 5′-end (Pvmsp-7C: nucleotides 1–390, Pvmsp-7H: nucleotides 1–471, Pvmsp-7I: nucleotides 1–525), central (Pvmsp-7C: nucleotides 391–717, Pvmsp-7H: nucleotides 472–771, Pvmsp-7I: nucleotides 526–789) and 3′-end (Pvmsp-7C: nucleotides 718–1,191, Pvmsp-7H: nucleotides 772–1,200, Pvmsp-7I: nucleotides 790–1,188).
: p<0.04, **: p<0.001, •: p<0.0001.
Figure 4Schematic representation of recombination fragments identified by RDP3 v.3.4 for Pvmsp-7C (A), Pvmsp-7H (B) and Pvmsp-7I (C).
The sequence names in black above the rectangles indicate the name of recombinant sequence. The rectangle with name to the right (name of the close relative minor parent) shown in different colors is a graphical representation of a sequence fragment that has potentially been derived through recombination. Only recombination events having p<0.03 were taken into account. SAL-I: Salvador strain, AMA: Amazonian, AND: Andean, CAR: Caribbean, ORI: Orinoco, PAC: Pacific.
Synonymous nucleotide substitution per synonymous site and nonsynonymous nucleotide substitution per nonsynonymous site and the standard deviations between three Pvmsp-7 genes.
| Synonymous nucleotide substitution per synonymous site (dS) | |||||||||
| 5′-end | Central region | 3′-end | |||||||
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||
|
| 0.241 (0.050) | 1.016 (0.199) | 0.879 (0.162) | ||||||
|
| 0.468 (0.085) | 0.518 (0.092) | 0.956 (0.167) | 0.790 (0.140) | 0.788 (0.138) | 0.136 (0.031) | |||
|
| |||||||||
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||
|
| 0.072 (0.017) | 1.430 (0.238) | 0.234 (0.035) | ||||||
|
| 0.125 (0.028) | 0.152 (0.031) | 1.729 (0.244) | 1.841 (0.306) | 0.323 (0.047) | 0.122 (0.028) | |||
5′-end from nucleotides 1 to 384 (amino acids 1 to 128), central region from nucleotides 385 to 807 (amino acids 129 to 269) and 3′-end from nucleotides 808 to 1,248 (amino acids 270 to 416), numbered according to the alignment in Fig S13.